HLA class II alleles evaluated for immune recognition by post-dUCBT patient PBMCs: third party alleles
| Patient no. . | HLA-DR . | HLA-DQ (B1) . | HLA-DP (B1) . | |
|---|---|---|---|---|
| B1 . | B4 . | |||
| 1 | 01:01 | 06:01 13:01 | ||
| 2 | ||||
| 3 | ||||
| 4 | 07:01 | 03:03 | 13:01 | |
| 5 | 15:01 | 06:02 | 06:01 | |
| 6 | ||||
| 7 | ||||
| 8 | 01:03 | 04:02 | 06:01 | |
| 9 | 08:01 | 04:02 | 13:01 | |
| 10 | 01:01 | |||
| 11 | ||||
| Patient no. . | HLA-DR . | HLA-DQ (B1) . | HLA-DP (B1) . | |
|---|---|---|---|---|
| B1 . | B4 . | |||
| 1 | 01:01 | 06:01 13:01 | ||
| 2 | ||||
| 3 | ||||
| 4 | 07:01 | 03:03 | 13:01 | |
| 5 | 15:01 | 06:02 | 06:01 | |
| 6 | ||||
| 7 | ||||
| 8 | 01:03 | 04:02 | 06:01 | |
| 9 | 08:01 | 04:02 | 13:01 | |
| 10 | 01:01 | |||
| 11 | ||||
Third party alleles, not present in recipient, predominant UCB, or nonengrafting UCB.